4164
承業醫
+0.05 (+0.20%)25.40313成交張數21.71本益比0.66股價淨值比4.37%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入20254,398年增 +22.2%
毛利率202526.1%最新一期
營業利益率20259.0%最新一期
每股盈餘20251.00年增 -1.0%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | -4.0% | +18.4% | +17.7% | -13.4% | -4.5% | +21.9% | +30.4% | -7.1% | +22.2% | |
| 營業成本合計 | – | -9.9% | +24.4% | +20.7% | -19.6% | -7.8% | +30.3% | +35.6% | +1.2% | +14.4% | |
| 營業毛利（毛損） | – | +11.1% | +6.1% | +10.3% | +3.1% | +2.3% | +6.2% | +18.4% | -28.9% | +51.3% | |
| 營業毛利（毛損）淨額 | – | +11.1% | +6.1% | +10.3% | +3.1% | +2.3% | +6.2% | +18.4% | -28.9% | +51.3% | |
| 推銷費用 | – | -17.2% | +9.5% | -0.5% | -4.2% | +3.0% | +50.5% | +18.7% | +23.2% | +79.4% | |
| 管理費用 | – | +27.6% | -13.4% | -13.3% | +15.1% | +21.8% | +2.1% | -1.0% | +7.3% | +0.7% | |
| 預期信用減損損失（利益） | – | – | – | – | – | -64.5% | – | -93.3% | -837.2% | – | |
| 營業費用合計 | – | +7.8% | -19.3% | +2.1% | +14.9% | +12.1% | +19.8% | +6.6% | +14.5% | +44.3% | |
| 營業利益（損失） | – | +14.5% | +30.4% | +15.1% | -3.1% | -3.9% | -3.6% | +28.9% | -61.1% | +66.6% | |
| 利息收入 | – | – | – | – | – | -20.6% | +31.0% | +65.1% | +26.2% | -20.6% | |
| 其他收入 | – | +221.1% | -29.9% | +106.3% | -66.2% | -1.7% | +21.9% | -39.5% | +575.4% | -62.1% | |
| 其他利益及損失淨額 | – | – | – | – | – | +387.0% | +72.6% | -91.2% | -52.7% | -323.5% | |
| 財務成本淨額 | – | +4.7% | +14.8% | -4.5% | -0.2% | -20.1% | +14.0% | +24.9% | +10.5% | +17.7% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | – | – | – | – | – | -103.9% | – | -37.6% | -627.1% | |
| 營業外收入及支出合計 | – | – | – | – | – | – | – | -769.3% | – | – | |
| 稅前淨利（淨損） | – | -111.5% | – | +29.4% | -2.6% | +5.8% | -1.5% | +15.6% | -60.1% | +40.2% | |
| 所得稅費用（利益）合計 | – | -5.8% | -20.4% | +71.2% | +17.3% | +9.6% | -14.1% | +41.0% | -69.9% | +114.7% | |
| 繼續營業單位本期淨利（淨損） | – | -155.6% | – | +22.8% | -7.0% | +4.8% | +2.2% | +9.4% | -57.1% | +23.7% | |
| 本期淨利（淨損） | – | -155.6% | – | +22.8% | -7.0% | +4.8% | +2.2% | +9.4% | -57.1% | +23.7% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | – | – | – | – | – | -65.2% | -720.9% | |
| 不重分類至損益之項目： | – | – | – | – | – | – | – | – | -65.2% | -720.9% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | – | – | – | -212.8% | – | -155.6% | – | -114.6% | |
| 與可能重分類之項目相關之所得稅 | – | -115.6% | – | -99.6% | -262.5% | – | -60.0% | +250.0% | -171.4% | – | |
| 後續可能重分類至損益之項目： | – | – | – | – | – | -212.6% | – | -155.7% | – | -114.6% | |
| 其他綜合損益（淨額） | – | – | -138.3% | – | – | -695.3% | – | -79.7% | +968.9% | -200.6% | |
| 本期綜合損益總額 | – | -39.5% | +434.9% | +38.3% | -0.5% | +1.8% | +7.0% | +7.5% | -53.0% | +3.5% | |
| 母公司業主（淨利∕損） | – | -154.5% | – | +22.2% | -7.3% | +4.2% | -6.6% | +17.5% | -59.8% | +10.6% | |
| 非控制權益（淨利∕損） | – | -255.0% | – | – | – | – | – | -80.1% | +122.7% | +178.8% | |
| 母公司業主（綜合損益） | – | -35.0% | +419.0% | +37.2% | -1.0% | +1.6% | -2.2% | +15.3% | -55.9% | -9.4% | |
| 非控制權益（綜合損益） | – | -255.0% | – | – | – | – | – | -80.4% | +139.7% | +161.9% | |
| 基本每股盈餘 | – | -154.4% | – | +22.0% | -10.6% | -4.0% | -9.1% | +15.4% | -60.4% | -1.0% | |
| 繼續營業單位淨利（淨損） | – | -154.9% | – | +21.8% | -20.7% | +11.8% | -9.2% | +14.1% | -56.6% | +2.0% | |
| 稀釋每股盈餘 | – | -154.9% | – | +21.8% | -20.7% | +11.8% | -9.2% | +14.1% | -56.6% | +2.0% | |
| 研究發展費用 | – | – | – | +308.5% | +28.3% | -100.0% | – | – | – | – | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | -100.0% | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | – | – | -100.0% | – | – | – | – | – | – | – | |
| 採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | -523.4% | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。